3SBio Inc.

3SBio Inc., a Chinese biopharma holding, produces oncology and hematology drugs such as TPIAO, Cipterbin, and Yisaipu, plus OTC hair‑loss treatments like Mandi. Collaborations with AstraZeneca, Lilly, and Samsung Bioepis bolster its pipeline and market reach.

Headquarters: China (CHN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 6,268
HQ: Shenyang

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
1530	3SBio Inc. Cap: 57.5B \| P/E: 22.8	EQUITY	HKG	HKD	KYG8875G1029	Active	📈